AUPH FY 2020 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50M+15660.4% YoY

Gross Profit

$50M100.0% margin

Operating Income

-$104M-208.1% margin

Net Income

-$103M-204.9% margin

EPS (Diluted)

$-0.87

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$77M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$464M

Total Liabilities

$56M

Stockholders' Equity

$408M

Cash & Equivalents

$272M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$318,000	+15660.4%
Gross Profit	$50M	$318,000	+15660.4%
Operating Income	-$104M	-$91M	-14.7%
Net Income	-$103M	-$88M	-16.2%